Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 1

Depression and drug utilization in an elderly population

Authors Raffaele Antonelli Incalz, Andrea Corsonello, Claudio Pedone, Francesco Corica, Pierugo Carbonin

Published 15 April 2005 Volume 2005:1(1) Pages 55—60

Raffaele Antonelli Incalzi1,4, Andrea Corsonello2,4, Claudio Pedone1,4, Francesco Corica3,4, Pierugo Carbonin1,4

1Centro di Medicina dell’Invecchiamento, Policlinico A Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy; 2Istituto Nazionale di Ricovero e Cura per Anziani (INRCA), Cosenza, Italy; 3Dipartimento di Medicina Interna, Università degli Studi di Messina, Messina, Italy; 4On behalf of the Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) investigators

Objective: To verify whether depression, defined as a 15-item Geriatric Depression Scale (GDS) > 6, is associated with greater drug utilization by elderly patients.

Population: 2568 patients enrolled in the Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) study.

Main outcome measure: Polypharmacy, ie, the daily use of at least 3 drugs, excluding antidepressant and anxiolytic agents, in the month prior to admission.

Method: Home therapy data were collected according to a validated procedure. Correlates of polypharmacy were assessed by logistic regression analysis in the whole population and in subgroups for which indexes of disease severity were available.

Results: GDS > 6 was found to be positively correlated with polypharmacy (odds ratio 1.22; 95% confidence interval 1.01–1.48) as were older age, comorbidity, hypertension, diabetes mellitus, congestive heart failure, and renal failure. Negative correlates of polypharmacy were smoking habit and alcohol consumption, and GDS > 6 was negatively associated with the use of analgesic (11.8% vs 15.6%, p = 0.012). In the subgroups with congestive heart failure and chronic renal failure, GDS > 6 was strictly associated with greater disease severity, but did not correlate with polypharmacy in multivariable models including indexes of disease severity.

Conclusions: Depressed mood is associated with polypharmacy in the broad elderly population. However, when indexes of disease severity were considered, the association was lost, indicating that depression is a marker of the burden of disease and does not increase drug consumption per se.

Keywords: depression, drugs, elderly, polypharmacy

Download Article [PDF] 

Readers of this article also read:

Pneumoscrotum: report of two different cases and review of the literature

Cochetti G, Barillaro F, Cottini E, D’Amico F, Pansadoro A, Pohja S, Boni A, Cirocchi R, Grassi V, Mancuso R, Silvi E, Ioannidou K, Egidi MG, Poli G, Mearini E

Therapeutics and Clinical Risk Management 2015, 11:581-587

Published Date: 9 April 2015

Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid)

Chen Y, Yang Z, Liu C, Wang C, Zhao S, Yang J, Sun H, Zhang Z, Kong D, Song C

International Journal of Nanomedicine 2013, 8:4315-4326

Published Date: 7 November 2013

Silver nanoparticle/chitosan oligosaccharide/poly(vinyl alcohol) nanofibers as wound dressings: a preclinical study

Li CW, Fu RQ, Yu CP, Li ZH, Guan HY, Hu DQ, Zhao DH, Lu LC

International Journal of Nanomedicine 2013, 8:4131-4145

Published Date: 1 November 2013

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA

Therapeutics and Clinical Risk Management 2013, 9:409-415

Published Date: 25 October 2013

Quality of life and glycemic control in adolescents with type 1 diabetes and the impact of an education intervention

Mostafa A Abolfotouh, Mofida M Kamal, Mohamed D El-Bourgy, et al

International Journal of General Medicine 2011, 4:141-152

Published Date: 20 February 2011

Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender

Yvonne Koh, Fatimah Bte Moideen Kutty, Shu Chuen Li

Therapeutics and Clinical Risk Management 2005, 1:39-48

Published Date: 15 April 2005

Elective open abdominal aortic aneurysm repair: a seven-year experience

Stuart MacKenzie, judith R Swan, Cate D’Este,  Allan D Spigelman

Therapeutics and Clinical Risk Management 2005, 1:27-31

Published Date: 15 April 2005